Search Within

Anas Younes

Formats
  1. Meeting Abstract (153)
  2. Journal Article (136)
  3. Book Section (13)
  4. Book Whole (4)
  5. Editorial (4)
  6. Review (4)
  7. Conference Paper (2)
  8. Research Letter (2)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (320)
  2. Department of Medicine (320)
  3. Executive Committee, Center for Hematologic Malignancies (320)
  4. Hematologic Malignancies, Division of (320)
  5. Lymphoma (320)
  6. Hematology-Oncology Fellows (98)

More Groups

People
  1. Andrew Zelenetz (89)
  2. Connie Batlevi (81)
  3. David Straus (74)
  4. Matthew Matasar (68)
  5. Anita Kumar (67)
  6. Paul Hamlin (67)

More People

Years
  1. 2024 (3)
  2. 2023 (7)
  3. 2022 (11)
  4. 2021 (13)
  5. 2020 (26)
  6. 2019 (53)

More Years

Publications
  1. Blood (91)
  2. Journal of Clinical Oncology (25)
  3. Hematological Oncology (22)
  4. Haematologica (16)
  5. British Journal of Haematology (13)
  6. Cancer Research (10)

More Publications

Publishers
  1. American Society of Hematology (99)
  2. American Society of Clinical Oncology (27)
  3. Wiley Blackwell (25)
  4. Nature Publishing Group (19)
  5. Springer (17)
  6. American Association for Cancer Research (16)

More Publishers

Results (320)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting oncogenic and epigenetic survival pathways in lymphoma
    Journal Article

    Leslie, L. A.; Younes, A.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • Brentuximab vedotin: The science of common sense
    Journal Article

    Lunning, M. A.; Younes, A.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas
    Journal Article

    Hagemeister, F.; Rodriguez, M. A.; Deitcher, S. R.; Younes, A.; Fayad, L.; Goy, A.; Dang, N. H.; Forman, A.; McLaughlin, P.; Medeiros, L. J.; more...
    British Journal of Haematology (2013)

    Fulltext@MSK | Save
  • XIV. The rationale for combining targeted and biological anti-lymphoma drugs
    Journal Article

    Younes, A.
    Hematological Oncology (2013)

    Fulltext@MSK | Save
  • Chemotherapeutic liver infusion
    Book Section

    Kemeny, N. E.; Younes, A.
    In Wanebo, H. J. (Eds.) Colorectal Cancer (1993)

    Fulltext@MSK | Save
  • Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β
    Journal Article

    Mathias, S.; Younes, A.; Kan, C. C.; Orlow, I.; Joseph, C.; Kolesnick, R. N.
    Science (1993)

    Fulltext@MSK | Save
  • Retinoic acid stimulates the protein kinase C pathway before activation of its β-nuclear receptor during human teratocarcinoma differentiation
    Journal Article

    Kurie, J. M.; Younes, A.; Miller, W. H. Jr; Burchert, M.; Chiu, C. F.; Kolesnick, R.; Dmitrovsky, E.
    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1993)

    Fulltext@MSK | Save
  • Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: The Memorial Sloan-Kettering experience
    Conference Paper

    Kemeny, N.; Younes, A.
    Elsevier Inc. (1992)

    Fulltext@MSK | Save
  • A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis
    Journal Article

    Michaeli, J.; Busquets, X.; Orlow, I.; Younes, A.; Colomer, D.; Marks, P. A.; Rifkind, R. A.; Kolesnick, R. N.
    Journal of Biological Chemistry (1992)

    Fulltext@MSK | Save
  • Interferon alpha‐2a and 5‐fluorouracil for advanced colorectal carcinoma: Assessment of activity and toxicity
    Journal Article

    Kemeny, N.; Younes, A.; Seiter, K.; Kelsen, D.; Sammarco, P.; Adams, L.; Derby, S.; Murray, P.; Houston, C.
    Cancer (1990)

    Fulltext@MSK | Save